We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
The Accelerated Access Review aims to speed up access to innovative drugs, devices and diagnostics for NHS patients.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Summarises progress made and outlines further critical steps required to ensure that the right drugs are available
Foresight project looking at how future scientific advances may affect our understanding of addiction and drug use.
Controlled drugs and precursor chemicals licensing fees information for individuals and companies.
£15 million Quantum Catalyst Fund will accelerate the adoption of quantum solutions by the public sector.
A 10-year plan to cut crime and save lives by reducing the supply and demand for drugs and delivering a high-quality treatment and recovery system.
A form to log controlled substances and what is being done with them.
This series brings together all documents relating to the UK government’s 10-year drugs strategy.
Form to notify of the theft or loss of controlled drugs or precursor chemicals.
Article in 'International Journal of Tuberculosis and Lung Disease'
The Accelerated Capability Environment is a unit within the Homeland Security Group tackling public safety and security challenges arising from evolving digital and data technology. ACE is part of the Home Office .
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
Agreement complements the signing today of a Memorandum of Understanding between the UK and Canada reflecting a new partnership on fusion energy
Public Assessment Report (PAR) discussing new risk minimisation measures which are being put into place for certain over-the-counter (OTC) stimulant laxatives.
Licence and registration application information for companies that deal in precursor chemicals.
Guidance outlining the structures and processes through which local partners in England should work together to reduce drug-related harm.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.